Browse by Uncontrolled Keywords
Number of items: 10.
A
Anyanwagu, U;
Mamza, J;
Donnelly, R;
Idris, I;
(2016)
Comparison of cardiovascular and metabolic outcomes in people with type 2 diabetes on insulin versus non-insulin glucose-lowering therapies (GLTs): A systematic review and meta-analysis of clinical trials.
Diabetes research and clinical practice, 121.
pp. 69-85.
ISSN 0168-8227
DOI: https://doi.org/10.1016/j.diabres.2016.09.002
Anyanwagu, U;
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2016)
Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
Heart (British Cardiac Society), 102 (19).
pp. 1581-7.
ISSN 1355-6037
DOI: https://doi.org/10.1136/heartjnl-2015-309164
B
Brewer, N;
Wright, CS;
Travier, N;
Cunningham, CW;
Hornell, J;
Pearce, N;
Jeffreys, M;
(2008)
A New Zealand linkage study examining the associations between A1C concentration and mortality.
Diabetes care, 31 (6).
pp. 1144-1149.
ISSN 0149-5992
DOI: https://doi.org/10.2337/dc07-2374
Full text not available from this repository.
G
Goring, S;
Hawkins, N;
Wygant, G;
Roudaut, M;
Townsend, R;
Wood, I;
Barnett, AH;
(2013)
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis.
Diabetes, obesity & metabolism, 16.
pp. 433-442.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12239
Full text not available from this repository.
Gross, JL;
Kramer, CK;
Leitão, CB;
Hawkins, N;
Viana, LV;
Schaan, BD;
Pinto, LC;
Rodrigues, TC;
Azevedo, MJ;
(2011)
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis.
Annals of internal medicine, 154.
pp. 672-679.
ISSN 0003-4819
DOI: https://doi.org/10.7326/0003-4819-154-10-201105170-00007
Full text not available from this repository.
M
Mamza, J;
Marlin, C;
Wang, C;
Chokkalingam, K;
Idris, I;
(2016)
DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes - A systematic review and meta-analysis.
Diabetes research and clinical practice, 116.
pp. 288-98.
ISSN 0168-8227
DOI: https://doi.org/10.1016/j.diabres.2016.04.029
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2016)
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.
Diabetes technology & therapeutics, 18 (2).
pp. 85-92.
ISSN 1520-9156
DOI: https://doi.org/10.1089/dia.2015.0052
Mungreiphy, NK;
Mamza, J;
Lakhdar, AF;
Bannister, M;
Elliott, J;
Idris, I;
(2015)
Clinical use and efficacy of biphasic insulin lispro 50/50 in people with insulin treated diabetes - a nationwide evaluation of clinical practice.
Current medical research and opinion, 31 (3).
pp. 493-501.
ISSN 0300-7995
DOI: https://doi.org/10.1185/03007995.2015.1008689
Full text not available from this repository.
N
Nazmi, A;
Huttly, SR;
Victora, CG;
Lima, RC;
Post, PR;
Elizalde, JWL;
Gerson, BMC;
(2007)
Hb A(1c) in relation to intrauterine growth among male adolescents in southern Brazil.
European journal of clinical nutrition, 61 (3).
pp. 434-437.
ISSN 0954-3007
DOI: https://doi.org/10.1038/sj.ejcn.1602535
Full text not available from this repository.
O
Olupot-Olupot, P;
Engoru, C;
Thompson, J;
Nteziyaremye, J;
Chebet, M;
Ssenyondo, T;
Dambisya, CM;
Okuuny, V;
Wokulira, R;
Amorut, D;
+8 more...
Ongodia, P;
Mpoya, A;
Williams, TN;
Uyoga, S;
Macharia, A;
Gibb, DM;
Walker, AS;
Maitland, K;
(2014)
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia.
BMC medicine, 12.
p. 67.
ISSN 1741-7015
DOI: https://doi.org/10.1186/1741-7015-12-67